Morningside Venture Investments
Signal active
Investment Firm
Overview
Morningside Venture Investments is an investment group that provides industry investments and social responsibility.
It was founded in 1986 and is based in Shanghai, China.
Highlights
Founded
1986
Industry
Financial Services
Employees
11-50
Investment
128
Lead Investment
62
Exits
14
Stages
Early Stage Venture, Late Stage Venture, Seed, Private Equity
Investor Type
Private Equity Firm, Venture Capital
Location
Asia
Contact Information
Social
Profile Resume
Morningside Venture Investments, established in 1986 and headquartered in Asia., specializes in Early Stage Venture, Late Stage Venture, Seed, Private Equity investments across Energy, CleanTech, Renewable Energy, Biotechnology, Health Care, Medical, Financial Services, Finance, Software, Life Science. The organization boasts a portfolio of 128 investments, with an average round size of $46.2M and 14 successful exits. Their recent investments include Clean Membranes, DNAtriX, Texas HALO Fund, DFJ Mercury, Apellis Pharmaceuticals. The highest investment round they participated in was $340.7B. Among their most notable exits are Clean Membranes and DNAtriX. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.
Investment portfolio
Morningside Venture Investments has made 128 investments. Their most recent investment was on Jan 03, 2024, when ENYO Pharma raised $42.6M.
Morningside Venture Investments has made 20 diversity investments. Their most recent diversity investment was on Nov 17, 2022, when Resilience Lab raised $15.0M.
investments
128
Diversity investments
20
Lead investments
62
Number of exits
14
Investments
128
| Annouced Date | Organization Name | Industry | Money Raised |
|---|---|---|---|
| Jan 01, 2024 | Suvera | Apps | null |
| Jan 01, 2024 | Pelicargo | Marketplace | null |
| Jan 03, 2024 | ENYO Pharma | Biotechnology | 42.6M |
| May 11, 2024 | Xencore Network | Manufacturing | null |
ENYO PharmaExits
14
Funding Timeline
Funding rounds
128
Investors
0
Funds
0
Funding Rounds
128
Morningside Venture Investments has raised 128 rounds. Their latest funding was raised on May 11, 2024 from a Series C - Xencore Network round.
| Annouced Date | Transaction Name | Number of Investors | Money Raised | Lead Investor |
|---|---|---|---|---|
| Jan 01, 2024 | Venture Round - Suvera | - | 0 | - |
| Jan 01, 2024 | Venture Round - Pelicargo | - | 0 | - |
| Jan 03, 2024 | Series C - ENYO Pharma | - | 42.6M | - |
| May 11, 2024 | Series C - Xencore Network | - | 0 | - |
Investors
0
There is no funding round available on this profile
Fund raised
2
Susa Ventures has raised a total of $590M across 6 funds, their latest being Susa Ventures Opportunities II. This fund was announced on Aug 30, 2021 and raised a total of $250M.
| Annouced Date | Fund Name | Money Raised |
|---|---|---|
| May 10, 2013 | OTPPLESS | 1.0M |
| May 11, 2013 | OTPPLESS | 1.0M |
Invest in industries
Recent Activity
There is no recent news or activity for this profile.